CoChat

Brief Communication: Better Ways To Question Patients about Adverse Medical Events: A Randomized, Controlled Trial

Bent, Stephen, Padula, Amy, Avins, Andrew L. · 2006 · Annals of Internal Medicine

The DOI matches its Crossref record, with a small difference in title or year; 11 of the 11 references it cites were found in a registry or an index.

Abstract

BACKGROUND: There is no standard method of identifying adverse events in clinical trials. OBJECTIVE: To determine whether 3 different methods of questioning patients about adverse events in a clinical trial affect the frequency of reported events. DESIGN: Randomized, single-blind, controlled trial. SETTING: A Veterans Administration medical center, San Francisco, California. PARTICIPANTS: Men 50 years of age or older who had benign prostatic hyperplasia. MEASUREMENT: Frequency of self-reported medical problems. INTERVENTION: The authors randomly assigned 214 men who were undergoing a 1-month, single-blind, placebo run-in period during an existing clinical trial to 3 groups to test different self-administered methods of assessing medical problems at the end of the run-in period. The first group was asked an open-ended question; the second group was asked an open-ended, defined question; and the third group was given a checklist of 53 common side effects. RESULTS: All 214 patients completed the study. Patients assigned to the checklist group reported a total of 238 adverse events; in comparison, patients who were asked an open-ended question or an open-ended, defined question reported 11 and 14 adverse events, respectively (P < 0.001). The percentage of patients reporting any adverse event was also much higher in the group assigned to the checklist (77%) than in the first group (14%) or second group (13%) (P < 0.001). LIMITATIONS: The study included only relatively healthy, well-educated, middle-aged men and assessed only self-reported medical problems after the participants had taken placebo for 1 month. All personnel overseeing the study were aware of the group assignments. CONCLUSIONS: Different methods of collecting patient data regarding adverse events lead to large differences in the reported rates of adverse events in clinical trials, potentially reducing the validity of comparisons between the side effect profiles of drugs and other interventions.

Overview

Integrity signals

Registry

Crossref · 10.7326/0003-4819-144-4-200602210-00007

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 11 references

Research works printed but not linked: 1

  1. Wallin J, 1981, Clin Ther, 3, 450

Cited by

See all 177

Metadata

Authors
Bent, S., Padula, A., & Avins, A. L.
Affiliations
San Francisco VA Medical Center (US)
Venue
Annals of Internal Medicine
Published
2006-02-21
Volume
144
Issue
4
Pages
257-261
ISSN
  • 0003-4819 (ISSN-L)
  • 1539-3704
OpenAlex
W2020924652
Cited by
177
References
11
Citations by year
2026: 5 · 2025: 5 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 10 · 2019: 10 · 2018: 7 · 2017: 10 · 2016: 13 · 2015: 9 · 2014: 8 · 2013: 12 · 2012: 4
FWCI
19.03
Type
journal article
Language
en
Open access
closed
Licence
www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations
  • Annals of Internal Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Annals of Internal Medicine
Funders
  • U.S. Public Health Service (1 K08 ATO1338-01)
  • National Institute of Diabetes and Digestive and Kidney Diseases (1 R01 DK56199-01, R01DK056199)
Topics
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Pharmacovigilance and Adverse Drug Reactions
  • Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
  • Social Sciences › Sociology and Political Science › Survey Methodology and Nonresponse
Keywords
adverse event reporting, self-administered questionnaire, open-ended questions, side effect profile, drug safety, benign prostatic hyperplasia, patient-reported outcomes
MeSH terms
Aged, Humans, Male, Middle Aged, Surveys and Questionnaires, Randomized Controlled Trials as Topic, Single-Blind Method, Drug-Related Side Effects and Adverse Reactions

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Brief Communication: Better Ways To Question Patients about Adverse Medical Events: A Randomized, Controlled Trial. https://app.cochat.ai/papers/10.7326/0003-4819-144-4-200602210-00007
The paper
Bent, S., Padula, A., & Avins, A. L. (2006). Brief Communication: Better Ways To Question Patients about Adverse Medical Events: A Randomized, Controlled Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-144-4-200602210-00007

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.